{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["amyloid", "brain ischemia", "curcumin", "dementia", "neurodegeneration", "neuroprotection", "tau protein"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35057429", "DateCompleted": {"Year": "2022", "Month": "02", "Day": "01"}, "DateRevised": {"Year": "2022", "Month": "02", "Day": "01"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "01", "Day": "07"}], "Language": ["eng"], "ELocationID": ["248", "10.3390/nu14020248"], "Journal": {"ISSN": "2072-6643", "JournalIssue": {"Volume": "14", "Issue": "2", "PubDate": {"Year": "2022", "Month": "Jan", "Day": "07"}}, "Title": "Nutrients", "ISOAbbreviation": "Nutrients"}, "ArticleTitle": "Post-Ischemic Brain Neurodegeneration in the Form of Alzheimer's Disease Proteinopathy: Possible Therapeutic Role of Curcumin.", "Abstract": {"AbstractText": ["For thousands of years, mankind has been using plant extracts or plants themselves as medicinal herbs. Currently, there is a great deal of public interest in naturally occurring medicinal substances that are virtually non-toxic, readily available, and have an impact on well-being and health. It has been noted that dietary curcumin is one of the regulators that may positively influence changes in the brain after ischemia. Curcumin is a natural polyphenolic compound with pleiotropic biological properties. The observed death of pyramidal neurons in the CA1 region of the hippocampus and its atrophy are considered to be typical changes for post-ischemic brain neurodegeneration and for Alzheimer's disease. Additionally, it has been shown that one of the potential mechanisms of severe neuronal death is the accumulation of neurotoxic amyloid and dysfunctional tau protein after cerebral ischemia. Post-ischemic studies of human and animal brains have shown the presence of amyloid plaques and neurofibrillary tangles. The significant therapeutic feature of curcumin is that it can affect the aging-related cellular proteins, i.e., amyloid and tau protein, preventing their aggregation and insolubility after ischemia. Curcumin also decreases the neurotoxicity of amyloid and tau protein by affecting their structure. Studies in animal models of cerebral ischemia have shown that curcumin reduces infarct volume, brain edema, blood-brain barrier permeability, apoptosis, neuroinflammation, glutamate neurotoxicity, inhibits autophagy and oxidative stress, and improves neurological and behavioral deficits. The available data suggest that curcumin may be a new therapeutic substance in both regenerative medicine and the treatment of neurodegenerative disorders such as post-ischemic neurodegeneration."]}, "AuthorList": [{"Identifier": ["0000-0003-0764-1356"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Ischemic and Neurodegenerative Brain Research, Mossakowski Medical Research Institute, Polish Academy of Sciences, 02-106 Warsaw, Poland."}], "LastName": "Pluta", "ForeName": "Ryszard", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Neonate and Infant Pathology, Medical University of Lublin, 20-093 Lublin, Poland."}], "LastName": "Furmaga-Jab\u0142o\u0144ska", "ForeName": "Wanda", "Initials": "W"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Ischemic and Neurodegenerative Brain Research, Mossakowski Medical Research Institute, Polish Academy of Sciences, 02-106 Warsaw, Poland."}], "LastName": "Januszewski", "ForeName": "S\u0142awomir", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pathophysiology, Medical University of Lublin, 20-090 Lublin, Poland."}], "LastName": "Czuczwar", "ForeName": "Stanis\u0142aw J", "Initials": "SJ"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Nutrients", "NlmUniqueID": "101521595", "ISSNLinking": "2072-6643"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Amyloid"}, {"RegistryNumber": "0", "NameOfSubstance": "Neuroprotective Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "tau Proteins"}, {"RegistryNumber": "IT942ZTH98", "NameOfSubstance": "Curcumin"}], "MeshHeadingList": [{"QualifierName": ["drug therapy", "etiology"], "DescriptorName": "Alzheimer Disease"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Amyloid"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["drug effects"], "DescriptorName": "Apoptosis"}, {"QualifierName": ["etiology"], "DescriptorName": "Atrophy"}, {"QualifierName": [], "DescriptorName": "Biological Availability"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Blood-Brain Barrier"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Brain Edema"}, {"QualifierName": ["complications", "drug therapy"], "DescriptorName": "Brain Ischemia"}, {"QualifierName": ["chemistry", "pharmacokinetics", "pharmacology"], "DescriptorName": "Curcumin"}, {"QualifierName": [], "DescriptorName": "Disease Models, Animal"}, {"QualifierName": ["physiology"], "DescriptorName": "Gastrointestinal Microbiome"}, {"QualifierName": [], "DescriptorName": "Gerbillinae"}, {"QualifierName": ["pathology"], "DescriptorName": "Hippocampus"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Neuroinflammatory Diseases"}, {"QualifierName": ["chemistry", "pharmacokinetics", "pharmacology"], "DescriptorName": "Neuroprotective Agents"}, {"QualifierName": ["drug effects"], "DescriptorName": "Oxidative Stress"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "tau Proteins"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Mok V.C.T., Lam B.Y.K., Wang Z., Liu W., Au L., Leung E.Y.L., Chen S., Yang J., Chu W.C.W., Lau A.Y.L., et al. Delayed-onset dementia after stroke or transient ischemic attack. Alzheimer\u2019s Dement. 2016;12:1167\u20131176. doi: 10.1016/j.jalz.2016.05.007.", "ArticleIdList": ["10.1016/j.jalz.2016.05.007", "27327542"]}, {"Citation": "Portegies M.L., Wolters F.J., Hofman A., Ikram M.K., Koudstaal P.J., Ikram M.A. Prestroke vascular pathology and the risk of recurrent stroke and poststroke dementia. Stroke. 2016;47:2119\u20132122. doi: 10.1161/STROKEAHA.116.014094.", "ArticleIdList": ["10.1161/STROKEAHA.116.014094", "27418596"]}, {"Citation": "Kim J.H., Lee Y. Dementia and death after stroke in older adults during a 10-year follow-up: Results from a competing risk model. J. Nutr. Health Aging. 2018;22:297\u2013301. doi: 10.1007/s12603-017-0914-3.", "ArticleIdList": ["10.1007/s12603-017-0914-3", "29380858"]}, {"Citation": "Pluta R., U\u0142amek-Kozio\u0142 M., Januszewski S., Czuczwar S.J. Amyloid pathology in the brain after ischemia. Folia Neuropathol. 2019;57:220\u2013226. doi: 10.5114/fn.2019.88450.", "ArticleIdList": ["10.5114/fn.2019.88450", "31588708"]}, {"Citation": "Goulay R., Romo L.M., Hol E.M., Dijkhuizen R.M. From stroke to dementia: A comprehensive review exposing tight interactions between stroke and amyloid-\u03b2 formation. Transl. Stroke Res. 2020;11:601\u2013614. doi: 10.1007/s12975-019-00755-2.", "ArticleIdList": ["10.1007/s12975-019-00755-2", "PMC7340665", "31776837"]}, {"Citation": "Johnson W., Onuma O., Owolabi M., Sachdev S. Stroke: A global response is needed. Bull. World Health Organ. 2016;94:634\u2013634A. doi: 10.2471/BLT.16.181636.", "ArticleIdList": ["10.2471/BLT.16.181636", "PMC5034645", "27708464"]}, {"Citation": "Pluta R., Bogucka-Kocka A., U\u0142amek-Kozio\u0142 M., Furmaga-Jab\u0142o\u0144ska W., Januszewski S., Brzozowska J., Jab\u0142o\u0144ski M., Kocki J. Neurogenesis and neuroprotection in postischemic brain neurodegeneration with Alzheimer phenotype: Is there a role for curcumin? Folia Neuropathol. 2015;53:89\u201399. doi: 10.5114/fn.2015.52405.", "ArticleIdList": ["10.5114/fn.2015.52405", "26216111"]}, {"Citation": "Bejot Y., Daubail B., Giroud M. Epidemiology of stroke and transient ischemic attacks: Current knowledge and perspectives. Rev. Neurol. 2016;172:59\u201368. doi: 10.1016/j.neurol.2015.07.013.", "ArticleIdList": ["10.1016/j.neurol.2015.07.013", "26718592"]}, {"Citation": "Murphy S.J.X., Werring D.J. Stroke: Causes and clinical features. Medicine. 2020;48:9. doi: 10.1016/j.mpmed.2020.06.002.", "ArticleIdList": ["10.1016/j.mpmed.2020.06.002", "PMC7409792", "32837228"]}, {"Citation": "Sekeljic V., Bataveljic D., Stamenkovic S., U\u0142amek M., Jab\u0142o\u0144ski M., Radenovic L., Pluta R., Andjus P.R. Cellular markers of neuroinflammation and neurogenesis after ischemic brain injury in the long-term survival rat model. Brain Struct. Funct. 2012;217:411\u2013420. doi: 10.1007/s00429-011-0336-7.", "ArticleIdList": ["10.1007/s00429-011-0336-7", "21706330"]}, {"Citation": "Pluta R. Brain ischemia as a bridge to Alzheimer\u2019s disease. Neural Regen. Res. 2022;17:791\u2013792. doi: 10.4103/1673-5374.322453.", "ArticleIdList": ["10.4103/1673-5374.322453", "PMC8530144", "34472473"]}, {"Citation": "Radenovic L., Nenadic M., U\u0142amek-Kozio\u0142 M., Januszewski S., Czuczwar S.J., Andjus P.R., Pluta R. Heterogeneity in brain distribution of activated microglia and astrocytes in a rat ischemic model of Alzheimer\u2019s disease after 2 years of survival. Aging. 2020;12:12251\u201312267. doi: 10.18632/aging.103411.", "ArticleIdList": ["10.18632/aging.103411", "PMC7343500", "32501292"]}, {"Citation": "Pluta R., Januszewski S., Czuczwar S.J. The role of gut microbiota in an ischemic stroke. Int. J. Mol. Sci. 2021;22:915. doi: 10.3390/ijms22020915.", "ArticleIdList": ["10.3390/ijms22020915", "PMC7831313", "33477609"]}, {"Citation": "Salminen A., Kauppinen A., Kaarniranta K. Hypoxia/ischemia activate processing of amyloid precursor protein: Impact of vascular dysfunction in the pathogenesis of Alzheimer\u2019s disease. J. Neurochem. 2017;140:536\u2013549. doi: 10.1111/jnc.13932.", "ArticleIdList": ["10.1111/jnc.13932", "27987381"]}, {"Citation": "Pluta R. Brain Ischemia: Alzheimer\u2019s Disease Mechanisms. Nova Science Publishers, Inc.; New York, NY, USA: 2019. p. 311."}, {"Citation": "De la Tremblaye P.B., Plamondon H. Impaired conditioned emotional response and object recognition are concomitant to neuronal damage in the amygdale and perirhinal cortex in middle-aged ischemic rats. Behav. Brain Res. 2011;219:227\u2013233. doi: 10.1016/j.bbr.2011.01.009.", "ArticleIdList": ["10.1016/j.bbr.2011.01.009", "21238489"]}, {"Citation": "Kiryk A., Pluta R., Figiel I., Mikosz M., U\u0142amek M., Niewiadomska G., Jab\u0142o\u0144ski M., Kaczmarek L. Transient brain ischemia due to cardiac arrest causes irreversible long-lasting cognitive injury. Behav. Brain Res. 2011;219:1\u20137. doi: 10.1016/j.bbr.2010.12.004.", "ArticleIdList": ["10.1016/j.bbr.2010.12.004", "21147171"]}, {"Citation": "Li J., Wang Y.J., Zhang M., Fang C.Q., Zhou H.D. Cerebral ischemia aggravates cognitive impairment in a rat model of Alzheimer\u2019s disease. Life Sci. 2011;89:86\u201392. doi: 10.1016/j.lfs.2011.04.024.", "ArticleIdList": ["10.1016/j.lfs.2011.04.024", "21620868"]}, {"Citation": "Brainin M., Tuomilehto J., Heiss W.D., Bornstein N.M., Bath P.M., Teuschl Y., Richard E., Guekht A., Quinn T. Post Stroke Cognition Study Group. Post-stroke cognitive decline: An update and perspectives for clinical research. Eur. J. Neurol. 2015;22:229\u2013238. doi: 10.1111/ene.12626.", "ArticleIdList": ["10.1111/ene.12626", "25492161"]}, {"Citation": "Cohan C.H., Neumann J.T., Dave K.R., Alekseyenko A., Binkert M., Stransky K., Lin H.W., Barnes C.A., Wright C.B., Perez-Pinzon M.A. Effect of cardiac arrest on cognitive impairment and hippocampal plasticity in middle-aged rats. PLoS ONE. 2015;10:e0124918.", "ArticleIdList": ["PMC4416883", "25933411"]}, {"Citation": "Surawan J., Areemit S., Tiamkao S., Sirithanawuthichai T., Saensak S. Risk factors associated with post-stroke dementia: A systematic review and meta-analysis. Neurol. Int. 2017;9:7216. doi: 10.4081/ni.2017.7216.", "ArticleIdList": ["10.4081/ni.2017.7216", "PMC5641826", "29071041"]}, {"Citation": "Bivard A., Lillicrap T., Mar\u00e9chal B., Garcia-Esperon C., Holliday E., Krishnamurthy V., Levi C.R., Parsons M. Transient ischemic attack results in delayed brain atrophy and cognitive decline. Stroke. 2018;49:384\u2013390. doi: 10.1161/STROKEAHA.117.019276.", "ArticleIdList": ["10.1161/STROKEAHA.117.019276", "29301970"]}, {"Citation": "Snowdon D.A., Greiner L.H., Mortimer J.A., Riley K.P., Greiner P.A., Markesbery W.R. Brain infarction and the clinical expression of Alzheimer disease: The Nun Study. JAMA. 1997;277:813\u2013817. doi: 10.1001/jama.1997.03540340047031.", "ArticleIdList": ["10.1001/jama.1997.03540340047031", "9052711"]}, {"Citation": "Hossmann K.A., Schmidt-Kastner R., Ophoff B.G. Recovery of integrative central nervous function after one hour global cerebro-circulatory arrest in normothermic cat. J. Neurol. Sci. 1987;77:305\u2013320. doi: 10.1016/0022-510X(87)90130-4.", "ArticleIdList": ["10.1016/0022-510X(87)90130-4", "3819770"]}, {"Citation": "Pluta R. The role of apolipoprotein E in the deposition of \u03b2-amyloid peptide during ischemia\u2013reperfusion brain injury. A model of early Alzheimer\u2019s disease. Ann. N. Y. Acad. Sci. 2000;903:324\u2013334. doi: 10.1111/j.1749-6632.2000.tb06383.x.", "ArticleIdList": ["10.1111/j.1749-6632.2000.tb06383.x", "10818522"]}, {"Citation": "Pluta R., U\u0142amek M., Jab\u0142o\u0144ski M. Alzheimer\u2019s mechanisms in ischemic brain degeneration. Anat. Rec. 2009;292:1863\u20131881. doi: 10.1002/ar.21018.", "ArticleIdList": ["10.1002/ar.21018", "19943340"]}, {"Citation": "Pluta R., Januszewski S., Jab\u0142o\u0144ski M., U\u0142amek M. Factors in creepy delayed neuronal death in hippocampus following brain ischemia-reperfusion injury with long-term survival. Acta Neurochir. 2010;106:37\u201341.", "ArticleIdList": ["19812917"]}, {"Citation": "Pluta R., U\u0142amek M., Jab\u0142o\u0144ski M. Consideration of the ischaemic basis and treatment of Alzheimer\u2019s disease. Folia Neuropathol. 2010;48:11\u201326.", "ArticleIdList": ["20383807"]}, {"Citation": "Pluta R., Kida E., Lossinsky A.S., Golabek A.A., Mossakowski M.J., Wisniewski H.M. Complete cerebral ischemia with short-term survival in rats induced by cardiac arrest. I. Extracellular accumulation of Alzheimer\u2019s \u03b2-amyloid protein precursor in the brain. Brain Res. 1994;649:323\u2013328. doi: 10.1016/0006-8993(94)91081-2.", "ArticleIdList": ["10.1016/0006-8993(94)91081-2", "7525011"]}, {"Citation": "Lee P.H., Bang O.Y., Hwang E.M., Lee J.S., Joo U.S., Mook-Jung I., Huh K. Circulating beta amyloid protein is elevated in patients with acute ischemic stroke. J. Neural. Transm. 2005;112:1371\u20131379. doi: 10.1007/s00702-004-0274-0.", "ArticleIdList": ["10.1007/s00702-004-0274-0", "15682267"]}, {"Citation": "Van Groen T., Puurunen K., Maki H.M., Sivenius J., Jolkkonen J. Transformation of diffuse beta-amyloid precursor protein and beta-amyloid deposits to plaques in the thalamus after transient occlusion of the middle cerebral artery in rats. Stroke. 2005;36:1551\u20131556. doi: 10.1161/01.STR.0000169933.88903.cf.", "ArticleIdList": ["10.1161/01.STR.0000169933.88903.cf", "15933257"]}, {"Citation": "Qi J., Wu H., Yang Y., Wand D., Chen Y., Gu Y., Liu T. Cerebral ischemia and Alzheimer\u2019s disease: The expression of amyloid-\u03b2 and apolipoprotein E in human hippocampus. J. Alzheimer\u2019s Dis. 2007;12:335\u2013341. doi: 10.3233/JAD-2007-12406.", "ArticleIdList": ["10.3233/JAD-2007-12406", "18198420"]}, {"Citation": "Zetterberg H., M\u00f6rtberg E., Song L., Chang L., Provuncher G.K., Patel P.P., Ferrell E., Fournier D.R., Kan C.W., Campbell T.G., et al. Hypoxia due to cardiac arrest induces a time-dependent increase in serum amyloid \u03b2 levels in humans. PLoS ONE. 2011;6:e28263. doi: 10.1371/journal.pone.0028263.", "ArticleIdList": ["10.1371/journal.pone.0028263", "PMC3237426", "22194817"]}, {"Citation": "Liu Y.H., Cao H.Y., Wang Y.R., Jiao S.S., Bu X.L., Zeng F., Wang Q.H., Li J., Deng J., Zhou H.D., et al. Serum A\u03b2 is predictive for short-term neurological deficits after acute ischemic stroke. Neurotox. Res. 2015;27:292\u2013299. doi: 10.1007/s12640-015-9518-z.", "ArticleIdList": ["10.1007/s12640-015-9518-z", "25612546"]}, {"Citation": "Kato T., Hirano A., Katagiri T., Sasaki H., Yamada S. Neurofibrillary tangle formation in the nucleus basalis of Meynert ipsilateral to a massive cerebral infarct. Ann. Neurol. 1988;23:620\u2013623. doi: 10.1002/ana.410230617.", "ArticleIdList": ["10.1002/ana.410230617", "3408244"]}, {"Citation": "Hesse C., Rosengren L., Andreasen N., Davidsson P., Vanderstichele H., Vanmechelen E., Blennow K. Transient increase in total tau but not phospho-tau in human cerebrospinal fluid after acute stroke. Neurosci. Lett. 2001;297:187\u2013190. doi: 10.1016/S0304-3940(00)01697-9.", "ArticleIdList": ["10.1016/S0304-3940(00)01697-9", "11137759"]}, {"Citation": "Bitsch A., Horn C., Kemmling Y., Seipelt M., Hellenbrand U., Stiefel M., Ciesielczyk B., Cepek L., Bahn E., Ratzka P., et al. Serum tau protein level as a marker of axonal damage in acute ischemic stroke. Eur. Neurol. 2002;47:45\u201351. doi: 10.1159/000047946.", "ArticleIdList": ["10.1159/000047946", "11803192"]}, {"Citation": "Wunderlich M.T., Lins H., Skalej M., Wallesch C.W., Goertler M. Neuron-specific enolase and tau protein as neurobiochemical markers of neuronal damage are related to early clinical course and long-term outcome in acute ischemic stroke. Clin. Neurol. Neurosurg. 2006;108:558\u2013563. doi: 10.1016/j.clineuro.2005.12.006.", "ArticleIdList": ["10.1016/j.clineuro.2005.12.006", "16457947"]}, {"Citation": "Wen Y., Yang S.H., Liu R., Perez E.J., Brun-Ziukemagel A.M., Koulen P., Simpkins J.W. Cdk5 is involved in NFT-like tauopathy induced by transient cerebral ischemia in female rats. Biochim. Biophys. Acta. 2007;1772:473\u2013483. doi: 10.1016/j.bbadis.2006.10.011.", "ArticleIdList": ["10.1016/j.bbadis.2006.10.011", "17113760"]}, {"Citation": "Kurzepa J., Bielewicz J., Grabarska A., Stelmasiak Z., Stryjecka-Zimmer M., Bartosik-Psujek H. Matrix metalloproteinase-9 contributes to the increase of tau protein in serum during acute ischemic stroke. J. Clin. Neurosci. 2010;17:997\u2013999. doi: 10.1016/j.jocn.2010.01.005.", "ArticleIdList": ["10.1016/j.jocn.2010.01.005", "20627731"]}, {"Citation": "Bielewicz J., Kurzepa J., Czekajska-Chehab E., Stelmasiak Z., Bartosik-Psujek H. Does serum tau protein predict the outcome of patients with ischemic stroke? J. Mol. Neurosci. 2011;43:241\u2013245. doi: 10.1007/s12031-010-9403-4.", "ArticleIdList": ["10.1007/s12031-010-9403-4", "20549384"]}, {"Citation": "M\u00f6rtberg E., Zetterberg H., Nordmark J., Blennow K., Catry C., Decraemer H., Vanmechelen E., Rubertsson S. Plasma tau protein in comatose patients after cardiac arrest treated with therapeutic hypothermia. Acta Anaesthesiol. Scand. 2011;55:1132\u20131138. doi: 10.1111/j.1399-6576.2011.02505.x.", "ArticleIdList": ["10.1111/j.1399-6576.2011.02505.x", "22092212"]}, {"Citation": "Randall J., M\u00f6rtberg E., Provuncher G.K., Fournier D.R., Duffy D.C., Rubertsson S., Blennow K., Zetterberg H., Wilson D.H. Tau proteins in serum predict neurological outcome after hypoxic brain injury from cardiac arrest: Results of a pilot study. Resuscitation. 2013;84:351\u2013356. doi: 10.1016/j.resuscitation.2012.07.027.", "ArticleIdList": ["10.1016/j.resuscitation.2012.07.027", "22885094"]}, {"Citation": "Lasek-Bal A., Jedrzejowska-Szypulka H., Rozycka J., Bal W., Kowalczyk A., Holecki M., Dulawa J., Lewin-Kowalik J. The presence of tau protein in blood as a potential prognostic factor in stroke patients. J. Physiol. Pharmacol. 2016;67:691\u2013696.", "ArticleIdList": ["28011949"]}, {"Citation": "Majd S., Power J.H., Koblar S.A., Grantham H.J. Early glycogen synthase kinase-3 and protein phosphatase 2A independent tau dephosphorylation during global brain ischaemia and reperfusion following cardiac arrest and the role of the adenosine monophosphate kinase pathway. Eur. J. Neurosci. 2016;44:1987\u20131997. doi: 10.1111/ejn.13277.", "ArticleIdList": ["10.1111/ejn.13277", "PMC5089632", "27177932"]}, {"Citation": "Bi M., Gladbach A., van Eersel J., Ittner A., Przybyla M., van Hummel A., Chua S.W., van der Hoven J., Lee W.S., M\u00fcller J., et al. Tau exacerbates excitotoxic brain damage in an animal model of stroke. Nat. Commun. 2017;8:473. doi: 10.1038/s41467-017-00618-0.", "ArticleIdList": ["10.1038/s41467-017-00618-0", "PMC5589746", "28883427"]}, {"Citation": "De Vos A., Bjerke M., Brouns R., De Roeck N., Jacobs D., Van den Abbeele L., Guldolf K., Zetterberg H., Blennow K., Engelborghs S., et al. Neurogranin and tau in cerebrospinal fluid and plasma of patients with acute ischemic stroke. BMC Neurol. 2017;17:170. doi: 10.1186/s12883-017-0945-8.", "ArticleIdList": ["10.1186/s12883-017-0945-8", "PMC5577791", "28854881"]}, {"Citation": "Fujii H., Takahashi T., Mukai T., Tanaka S., Hosomi N., Maruyama H., Sakai N., Matsumoto M. Modifications of tau protein after cerebral ischemia and reperfusion in rats are similar to those occurring in Alzheimer\u2019s disease\u2014Hyperphosphorylation and cleavage of 4- and 3-repeat tau. J. Cereb. Blood Flow Metab. 2017;37:2441\u20132457. doi: 10.1177/0271678X16668889.", "ArticleIdList": ["10.1177/0271678X16668889", "PMC5531343", "27629097"]}, {"Citation": "Khan S., Yuldasheva N.Y., Batten T.F.C., Pickles A.R., Kellett K.A.B., Saha S. Tau pathology and neurochemical changes associated with memory dysfunction in an optimized murine model of global cerebral ischaemia\u2014A potential model for vascular dementia? Neurochem. Int. 2018;118:134\u2013144. doi: 10.1016/j.neuint.2018.04.004.", "ArticleIdList": ["10.1016/j.neuint.2018.04.004", "29649504"]}, {"Citation": "Kovalska M., Tothova B., Kovalska L., Tatarkova Z., Kalenska D., Tomascova A., Adamkov M., Lehotsky J. Association of induced hyperhomocysteinemia with Alzheimer\u2019s disease-like neurodegene-ration in rat cortical neurons after global ischemia-reperfusion injury. Neurochem. Res. 2018;43:1766\u20131778. doi: 10.1007/s11064-018-2592-x.", "ArticleIdList": ["10.1007/s11064-018-2592-x", "30003389"]}, {"Citation": "Pluta R., U\u0142amek-Kozio\u0142 M., Januszewski S., Czuczwar S.J. Tau protein dysfunction after brain ischemia. J. Alzheimer\u2019s Dis. 2018;66:429\u2013437. doi: 10.3233/JAD-180772.", "ArticleIdList": ["10.3233/JAD-180772", "PMC6218135", "30282370"]}, {"Citation": "Pluta R., Bogucka-Kocka A., U\u0142amek-Kozio\u0142 M., Bogucki J., Czuczwar S.J. Ischemic tau protein gene induction as an additional key factor driving development of Alzheimer\u2019s phenotype changes in CA1 area of hippocampus in an ischemic model of Alzheimer\u2019s disease. Pharmacol. Rep. 2018;70:881\u2013884. doi: 10.1016/j.pharep.2018.03.004.", "ArticleIdList": ["10.1016/j.pharep.2018.03.004", "30096486"]}, {"Citation": "Hatsuta H., Takao M., Nogami A., Uchino A., Sumikura H., Takata T., Morimoto S., Kanemaru K., Adachi T., Arai T., et al. Tau and TDP-43 accumulation of the basal nucleus of Meynert in individuals with cerebral lobar infarcts or hemorrhage. Acta Neuropathol. Commun. 2019;7:49. doi: 10.1186/s40478-019-0700-z.", "ArticleIdList": ["10.1186/s40478-019-0700-z", "PMC6437979", "30922392"]}, {"Citation": "Pluta R., Czuczwar S.J., Januszewski S., Jab\u0142o\u0144ski M. The many faces of post-ischemic tau protein in brain neurodegeneration of the Alzheimer\u2019s disease type. Cells. 2021;10:2213. doi: 10.3390/cells10092213.", "ArticleIdList": ["10.3390/cells10092213", "PMC8465797", "34571862"]}, {"Citation": "U\u0142amek-Kozio\u0142 M., Kocki J., Bogucka-Kocka A., Petniak A., Gil-Kulik P., Januszewski S., Bogucki J., Jab\u0142o\u0144ski M., Furmaga-Jab\u0142o\u0144ska W., Brzozowska J., et al. Dysregulation of autophagy, mitophagy and apoptotic genes in the medial temporal lobe cortex in an ischemic model of Alzheimer\u2019s disease. J. Alzheimer\u2019s Dis. 2016;54:113\u2013121. doi: 10.3233/JAD-160387.", "ArticleIdList": ["10.3233/JAD-160387", "PMC5008226", "27472881"]}, {"Citation": "U\u0142amek-Kozio\u0142 M., Kocki J., Bogucka-Kocka A., Januszewski S., Bogucki J., Czuczwar S.J., Pluta R. Autophagy, mitophagy and apoptotic gene changes in the hippocampal CA1 area in a rat ischemic model of Alzheimer\u2019s disease. Pharmacol Rep. 2017;69:1289\u20131294. doi: 10.1016/j.pharep.2017.07.015.", "ArticleIdList": ["10.1016/j.pharep.2017.07.015", "29128811"]}, {"Citation": "U\u0142amek-Kozio\u0142 M., Czuczwar S.J., Kocki J., Januszewski S., Bogucki J., Bogucka-Kocka A., Pluta R. Dysregulation of autophagy, mitophagy, and apoptosis genes in the CA3 region of the hippocampus in the ischemic model of Alzheimer\u2019s disease in the rat. J. Alzheimer\u2019s Dis. 2019;72:1279\u20131286. doi: 10.3233/JAD-190966.", "ArticleIdList": ["10.3233/JAD-190966", "PMC6971835", "31707369"]}, {"Citation": "Kocki J., U\u0142amek-Kozio\u0142 M., Bogucka-Kocka A., Januszewski S., Jab\u0142o\u0144ski M., Gil-Kulik P., Brzozowska J., Petniak A., Furmaga-Jab\u0142o\u0144ska W., Bogucki J., et al. Dysregulation of amyloid precursor protein, \u03b2-secretase, presenilin 1 and 2 genes in the rat selectively vulnerable CA1 subfield of hippocampus following transient global brain ischemia. J. Alzheimer\u2019s Dis. 2015;47:1047\u20131056. doi: 10.3233/JAD-150299.", "ArticleIdList": ["10.3233/JAD-150299", "PMC4923727", "26401782"]}, {"Citation": "Pluta R., Kocki J., U\u0142amek-Kozio\u0142 M., Petniak A., Gil-Kulik P., Januszewski S., Bogucki J., Jab\u0142o\u0144ski M., Brzozowska J., Furmaga-Jab\u0142o\u0144ska W., et al. Discrepancy in expression of \u03b2-secretase and amyloid-\u03b2 protein precursor in Alzheimer-related genes in the rat medial temporal lobe cortex following transient global brain ischemia. J. Alzheimer\u2019s Dis. 2016;51:1023\u20131031. doi: 10.3233/JAD-151102.", "ArticleIdList": ["10.3233/JAD-151102", "26890784"]}, {"Citation": "Pluta R., U\u0142amek-Kozio\u0142 M., Kocki J., Bogucki J., Januszewski S., Bogucka-Kocka A., Czuczwar S.J. Expression of the tau protein and amyloid protein precursor processing genes in the CA3 area of the hippocampus in the ischemic model of Alzheimer\u2019s disease in the rat. Mol. Neurobiol. 2020;57:1281\u20131290. doi: 10.1007/s12035-019-01799-z.", "ArticleIdList": ["10.1007/s12035-019-01799-z", "PMC7031177", "31713815"]}, {"Citation": "Herson P.S., Traystman R.J. Animal models of stroke: Translational potential at present and in 2050. Future Neurol. 2014;9:541\u2013551. doi: 10.2217/fnl.14.44.", "ArticleIdList": ["10.2217/fnl.14.44", "PMC4266275", "25530721"]}, {"Citation": "Aggarwal B.B., Sundaram C., Malani N., Ichikawa H. Curcumin: The Indian solid gold. Adv. Exp. Med. Biol. 2007;595:1\u201375.", "ArticleIdList": ["17569205"]}, {"Citation": "U\u0142amek-Kozio\u0142 M., Czuczwar S.J., Januszewski S., Pluta R. Substantiation for the use of curcumin during the development of neurodegeneration after brain ischemia. Int. J. Mol. Sci. 2020;21:517. doi: 10.3390/ijms21020517.", "ArticleIdList": ["10.3390/ijms21020517", "PMC7014172", "31947633"]}, {"Citation": "Peterson C.T., Vaughn A.R., Sharma V., Chopra D., Mills P.J., Peterson S.N., Sivamani R.K. Effects of turmeric and curcumin dietary supplementation on human gut microbiota: A double-blind, randomized, placebo-controlled pilot study. J. Evid.-Based Integr. Med. 2018;23:2515690X18790725. doi: 10.1177/2515690X18790725.", "ArticleIdList": ["10.1177/2515690X18790725", "PMC6083746", "30088420"]}, {"Citation": "Thiyagarajan M., Sharma S.S. Neuroprotective effect of curcumin in middle cerebral artery occlusion induced focal cerebral ischemia in rats. Life Sci. 2004;74:969\u2013985. doi: 10.1016/j.lfs.2003.06.042.", "ArticleIdList": ["10.1016/j.lfs.2003.06.042", "14672754"]}, {"Citation": "Jiang J., Wang W., Sun Y.J., Hu M., Li F., Zhu D.Y. Neuroprotective effect of curcumin on focal cerebral ischemic rats by preventing blood\u2013brain barrier damage. Eur. J. Pharmacol. 2007;561:54\u201362. doi: 10.1016/j.ejphar.2006.12.028.", "ArticleIdList": ["10.1016/j.ejphar.2006.12.028", "17303117"]}, {"Citation": "Dohare P., Garg P., Jain V., Nath C., Ray M. Dose dependence and therapeutic window for the neuroprotective effects of curcumin in thromboembolic model of rat. Behav. Brain Res. 2008;193:289\u2013297. doi: 10.1016/j.bbr.2008.06.012.", "ArticleIdList": ["10.1016/j.bbr.2008.06.012", "18611416"]}, {"Citation": "Zhao J., Yu S., Zheng W., Feng G., Luo G., Wang L., Zhao Y. Curcumin improves outcomes and attenuates focal cerebral ischemic injury via antiapoptotic mechanisms in rats. Neurochem. Res. 2010;35:374\u2013379. doi: 10.1007/s11064-009-0065-y.", "ArticleIdList": ["10.1007/s11064-009-0065-y", "19774461"]}, {"Citation": "Tyagi N., Qipshidze N., Munjal C., Vacek J.C., Metreveli N., Givvimani S., Tyagi S.C. Tetrahydrocurcumin ameliorates homocysteinylated cytochrome-c mediated autophagy in hyperhomocysteinemia mice after cerebral ischemia. J. Mol. Neurosci. 2012;47:128\u2013138. doi: 10.1007/s12031-011-9695-z.", "ArticleIdList": ["10.1007/s12031-011-9695-z", "PMC3609416", "22212488"]}, {"Citation": "Funk J.L., Frye J.B., Davis-Gorman G., Spera A.L., Bernas M.J., Witte M.H., Weinand M.E., Timmermann B.N., McDonagh P.F., Ritter L. Curcuminoids limit neutrophil-mediated reperfusion injury in experimental stroke by targeting the endothelium. Microcirculation. 2013;20:544\u2013554. doi: 10.1111/micc.12054.", "ArticleIdList": ["10.1111/micc.12054", "PMC3740077", "23464666"]}, {"Citation": "Kelly-Cobbs A.I., Prakash R., Li W., Pillai B., Hafez S., Coucha M., Johnson M.H., Ogbi S.N., Fagan S.C., Ergul A. Targets of vascular protection in acute ischemic stroke differ in type 2 diabetes. Am. J. Physiol. Heart Circ. Physiol. 2013;304:H806\u2013H815. doi: 10.1152/ajpheart.00720.2012.", "ArticleIdList": ["10.1152/ajpheart.00720.2012", "PMC3602773", "23335797"]}, {"Citation": "Kalani A., Chaturvedi P., Kamat P.K., Maldonado C., Bauer P., Joshua I.G., Tyagi S.C., Tyagi N. Curcumin-loaded embryonic stem cell exosomes restored neurovascular unit following ischemia-reperfusion injury. Int. J. Biochem. Cell Biol. 2016;79:360\u2013369. doi: 10.1016/j.biocel.2016.09.002.", "ArticleIdList": ["10.1016/j.biocel.2016.09.002", "PMC5067233", "27594413"]}, {"Citation": "Miao Y., Zhao S., Gao Y., Wang R., Wu Q., Wu H., Luo T. Curcumin pretreatment attenuates inflammation and mitochondrial dysfunction in experimental stroke: The possible role of Sirt1 signaling. Brain Res. Bull. 2016;121:9\u201315. doi: 10.1016/j.brainresbull.2015.11.019.", "ArticleIdList": ["10.1016/j.brainresbull.2015.11.019", "26639783"]}, {"Citation": "Shah F.A., Gim S.A., Sung J.H., Jeon S.J., Kim M.O., Koh P.O. Identification of proteins regulated by curcumin in cerebral ischemia. J. Surg. Res. 2016;201:141\u2013148. doi: 10.1016/j.jss.2015.10.025.", "ArticleIdList": ["10.1016/j.jss.2015.10.025", "26850195"]}, {"Citation": "Zhang Y., Yan Y., Cao Y., Yang Y., Zhao Q., Jing R., Jing R., Hu J., Bao J. Potential therapeutic and protective effect of curcumin against stroke in the male albino stroke-induced model rats. Life Sci. 2017;183:45\u201349. doi: 10.1016/j.lfs.2017.06.023.", "ArticleIdList": ["10.1016/j.lfs.2017.06.023", "28663065"]}, {"Citation": "Huang L., Chen C., Zhang X., Li X., Chen Z., Yang C., Liang X., Zhu G., Xu Z. Neuroprotective effect of curcumin against cerebral ischemia-reperfusion via mediating autophagy and inflammation. J. Mol. Neurosci. 2018;64:129\u2013139. doi: 10.1007/s12031-017-1006-x.", "ArticleIdList": ["10.1007/s12031-017-1006-x", "29243061"]}, {"Citation": "Xia M., Ye Z., Shi Y., Zhou L., Hua Y. Curcumin improves diabetes mellitus associated cerebral infarction by increasing the expression of GLUT1 and GLUT3. Mol. Med. Rep. 2018;17:1963\u20131969. doi: 10.3892/mmr.2017.8085.", "ArticleIdList": ["10.3892/mmr.2017.8085", "29257220"]}, {"Citation": "Zhang Y., Fang M., Sun Y., Zhang T., Shi N., Li J., Jin L., Liu K., Fu J. Curcumin attenuates cerebral ischemia injury in sprague-dawley rats and PC12 cells by suppressing overactivated autophagy. J. Photochem. Photobiol. B. 2018;184:1\u20136. doi: 10.1016/j.jphotobiol.2018.05.010.", "ArticleIdList": ["10.1016/j.jphotobiol.2018.05.010", "29777940"]}, {"Citation": "Wang Q., Sun A.Y., Simonyi A., Jensen M.D., Shelat P.B., Rottinghaus G.E., MacDonald R.S., Miller D.K., Lubahn D.E., Weisman G.A., et al. Neuroprotective mechanisms of curcumin against cerebral ischemia-induced neuronal apoptosis and behavioral deficits. J. Neurosci. Res. 2005;82:138\u2013148. doi: 10.1002/jnr.20610.", "ArticleIdList": ["10.1002/jnr.20610", "16075466"]}, {"Citation": "Altinay S., Cabalar M., Isler C., Yildirim F., Celik D.S., Zengi O., Tas A., Gulcubuk A. Is chronic curcumin supplementation neuroprotective against ischemia for antioxidant activity, neurological deficit, or neuronal apoptosis in an experimental stroke model? Turk. Neurosurg. 2017;27:537\u2013545.", "ArticleIdList": ["27593816"]}, {"Citation": "Mukherjee A., Sarkar S., Jana S., Swarnakar S., Das N. Neuro-protective role of nanocapsulated curcumin against cerebral ischemia-reperfusion induced oxidative injury. Brain Res. 2019;1704:164\u2013173. doi: 10.1016/j.brainres.2018.10.016.", "ArticleIdList": ["10.1016/j.brainres.2018.10.016", "30326199"]}, {"Citation": "Li Y., Li J., Li S., Wang X., Liu B., Fu Q., Ma S. Curcumin attenuates glutamate neurotoxicity in the hippocampus by suppression of ER stress-associated TXNIP/NLRP3 inflammasome activation in a manner dependent on AMPK. Toxicol. Appl. Pharmacol. 2015;286:53\u201363. doi: 10.1016/j.taap.2015.03.010.", "ArticleIdList": ["10.1016/j.taap.2015.03.010", "25791922"]}, {"Citation": "Hou Y., Wang J., Feng J. The neuroprotective effects of curcumin are associated with the regulation of the reciprocal function between autophagy and HIF-1\u03b1 in cerebral ischemia-reperfusion injury. Drug Des. Dev. Ther. 2019;13:1135\u20131144. doi: 10.2147/DDDT.S194182.", "ArticleIdList": ["10.2147/DDDT.S194182", "PMC6461000", "31040648"]}, {"Citation": "Liu W., Zhai Y., Heng X., Che F.Y., Chen W., Sun D., Zhai G. Oral bioavailability of curcumin: Problems and advancements. J. Drug Target. 2016;24:694\u2013702. doi: 10.3109/1061186X.2016.1157883.", "ArticleIdList": ["10.3109/1061186X.2016.1157883", "26942997"]}, {"Citation": "Liu S., Cao Y., Qu M., Zhang Z., Feng L., Ye Z., Xiao M., Hou S.T., Zheng R., Han Z. Curcumin protects against stroke and increases levels of Notch intracellular domain. Neurol. Res. 2016;38:553\u2013559. doi: 10.1080/01616412.2016.1187804.", "ArticleIdList": ["10.1080/01616412.2016.1187804", "27320251"]}, {"Citation": "Zhang Z., Chen Y., Xiang L., Wang Z., Xiao G.G., Hu J. Effect of curcumin on the diversity of gut microbiota in ovariectomized rats. Nutrients. 2017;9:1146. doi: 10.3390/nu9101146.", "ArticleIdList": ["10.3390/nu9101146", "PMC5691762", "29048369"]}, {"Citation": "Lan C., Chen X., Zhang Y., Wang W., Wang W.E., Liu Y., Cai Y., Ren H., Zheng S., Zhou L., et al. Curcumin prevents strokes in stroke-prone spontaneously hypertensive rats by improving vascular endothelial function. BMC Cardiovasc. Disord. 2018;18:43. doi: 10.1186/s12872-018-0768-6.", "ArticleIdList": ["10.1186/s12872-018-0768-6", "PMC5831583", "29490624"]}, {"Citation": "Xie C.J., Gu A.P., Cai J., Wu Y., Chen R.C. Curcumin protects neural cells against ischemic injury in N2a cells and mouse brain with ischemic stroke. Brain Behav. 2018;8:e00921. doi: 10.1002/brb3.921.", "ArticleIdList": ["10.1002/brb3.921", "PMC5822585", "29484272"]}, {"Citation": "Li W., Suwanwela N.C., Patumraj S. Curcumin by down-regulating NF-kB and elevating Nrf2, reduces brain edema and neurological dysfunction after cerebral I/R. Microvasc. Res. 2016;106:117\u2013127. doi: 10.1016/j.mvr.2015.12.008.", "ArticleIdList": ["10.1016/j.mvr.2015.12.008", "26686249"]}, {"Citation": "Jia G., Tan B., Ma J., Zhang L., Jin X., Li C. Prdx6 upregulation by curcumin attenuates ischemic oxidative damage via SP1 in rats after stroke. BioMed Res. Int. 2017;2017:6597401. doi: 10.1155/2017/6597401.", "ArticleIdList": ["10.1155/2017/6597401", "PMC5449737", "28596967"]}, {"Citation": "Yan R., Vassar R. Targeting the beta secretase BACE1 for Alzheimer\u2019s disease therapy. Lancet Neurol. 2014;13:319\u2013329. doi: 10.1016/S1474-4422(13)70276-X.", "ArticleIdList": ["10.1016/S1474-4422(13)70276-X", "PMC4086426", "24556009"]}, {"Citation": "Yang F., Lim G.P., Begum A.N., Ubeda O.J., Simmons M.R., Ambegaokar S.S., Chen P.P., Kayed R., Glabe C.G., Frautschy S.A., et al. Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J. Biol. Chem. 2005;280:5892\u20135901. doi: 10.1074/jbc.M404751200.", "ArticleIdList": ["10.1074/jbc.M404751200", "15590663"]}, {"Citation": "Cole G.M., Teter B., Frautschy S.A. Neuroprotective effects of curcumin. Adv. Exp. Med. Biol. 2007;595:197\u2013212.", "ArticleIdList": ["PMC2527619", "17569212"]}, {"Citation": "Narlawar R., Baumann K., Schubenel R., Schmidt B. Curcumin derivatives inhibit or modulate beta-amyloid precursor protein metabolism. Neurodegener. Dis. 2007;4:88\u201393. doi: 10.1159/000101832.", "ArticleIdList": ["10.1159/000101832", "17596702"]}, {"Citation": "Zhang C., Browne A., Child D., Tanzi R.E. Curcumin decreases amyloid-\u03b2 peptide levels by attenuating the maturation of amyloid-\u03b2 precursor protein. J. Biol. Chem. 2010;285:28472\u201328480. doi: 10.1074/jbc.M110.133520.", "ArticleIdList": ["10.1074/jbc.M110.133520", "PMC2937872", "20622013"]}, {"Citation": "Huang H.C., Xu K., Jiang Z.F. Curcumin-mediated neuroprotection against amyloid-beta-induced mitochondrial dysfunction involves the inhibition of GSK-3beta. J. Alzheimer\u2019s Dis. 2012;32:981\u2013996. doi: 10.3233/JAD-2012-120688.", "ArticleIdList": ["10.3233/JAD-2012-120688", "22886017"]}, {"Citation": "Huang X., Atwood C.S., Moir R.D., Hartshorn M.A., Tanzi R.E., Bush A.I. Trace metal contamination initiates the apparent auto-aggregation, amyloidosis, and oligomerization of Alzheimer\u2019s A\u03b2 peptides. J. Biol. Inorg. Chem. 2004;9:954\u2013960. doi: 10.1007/s00775-004-0602-8.", "ArticleIdList": ["10.1007/s00775-004-0602-8", "15578276"]}, {"Citation": "Masuda Y., Fukuchi M., Yatagawa T., Tada M., Takeda K., Irie K., Akagi K.-I., Monobe Y., Imazawa T., Takegoshi K. Solid-state NMR analysis of interaction sites of curcumin and 42-residue amyloid \u03b2-protein fibrils. Bioorganic Med. Chem. 2011;19:5967\u20135974. doi: 10.1016/j.bmc.2011.08.052.", "ArticleIdList": ["10.1016/j.bmc.2011.08.052", "21924918"]}, {"Citation": "Kim H., Park B.S., Lee K.G., Choi C.Y., Jang S.S., Kim Y.H., Lee S.E. Effects of naturally occurring compounds on fibril formation and oxidative stress of beta-amyloid. J. Agric. Food Chem. 2005;53:8537\u20138541. doi: 10.1021/jf051985c.", "ArticleIdList": ["10.1021/jf051985c", "16248550"]}, {"Citation": "Feng H.L., Fan H., Dang H.Z., Chen X.P., Ren Y., Yang J.D., Wang P.W. Neuroprotective effect of curcumin to Abeta of double transgenic mice with Alzheimer\u2019s disease. J. Chin. Mater. Med. 2014;39:3846\u20133849.", "ArticleIdList": ["25612452"]}, {"Citation": "Hu S., Maiti P., Ma Q., Zuo X., Jones M.R., Cole G.M., Frautschy S.A. Clinical development of curcumin in neurodegenerative disease. Expert Rev. Neurother. 2015;15:629\u2013637. doi: 10.1586/14737175.2015.1044981.", "ArticleIdList": ["10.1586/14737175.2015.1044981", "PMC6800094", "26035622"]}, {"Citation": "Koronyo Y., Biggs D., Barron E., Boyer D.S., Pearlman J.A., Au W.J., Kile S.J., Blanco A., Fuchs D.T., Ashfaq A., et al. Retinal amyloid pathology and proof-of-concept imaging trial in Alzheimer\u2019s disease. JCI Insight. 2017;2:e93621. doi: 10.1172/jci.insight.93621.", "ArticleIdList": ["10.1172/jci.insight.93621", "PMC5621887", "28814675"]}, {"Citation": "Ono K., Hasegawa K., Naiki H., Yamada M. Curcumin has potent anti amyloidogenic effects for Alzheimer\u2019s beta-amyloid fibrils in vitro. J. Neurosci. Res. 2004;75:742\u2013750. doi: 10.1002/jnr.20025.", "ArticleIdList": ["10.1002/jnr.20025", "14994335"]}, {"Citation": "Mishra S., Palanivelu K. The effect of curcumin (turmeric) on Alzheimer\u2019s disease: An overview. Ann. Indian Acad. Neurol. 2008;11:13\u201319. doi: 10.4103/0972-2327.40220.", "ArticleIdList": ["10.4103/0972-2327.40220", "PMC2781139", "19966973"]}, {"Citation": "Thapa A., Jett S.D., Chi E.Y. Curcumin attenuates amyloid-\u03b2 aggregate toxicity and modulates amyloid-\u03b2 aggregation pathway. ACS Chem. Neurosci. 2015;7:56\u201368. doi: 10.1021/acschemneuro.5b00214.", "ArticleIdList": ["10.1021/acschemneuro.5b00214", "26529184"]}, {"Citation": "Brahmkhatri V., Sharma N., Punnepalli S., D\u2019Souza A., Raghothama S., Atreya H.S. Curcumin nanoconjugate inhibits aggregation of N-terminal region (A\u03b2-16) of an amyloid beta peptide. N. J. Chem. 2018;42:19881\u201319892. doi: 10.1039/C8NJ03541E.", "ArticleIdList": ["10.1039/C8NJ03541E"]}, {"Citation": "Mithu V.S., Sarkar B., Bhowmik D., Das A.K., Chandrakesan M. Curcumin alters the salt bridge-containing turn region in amyloid \u03b2 (1\u201342) aggregates. J. Biol. Chem. 2014;289:11122\u201311131. doi: 10.1074/jbc.M113.519447.", "ArticleIdList": ["10.1074/jbc.M113.519447", "PMC4036251", "24599958"]}, {"Citation": "Garcia-Alloza M., Borrelli L.A., Rozkalne A., Hyman B.T., Bacskai B.J. Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model. J. Neurochem. 2007;102:1095\u20131104. doi: 10.1111/j.1471-4159.2007.04613.x.", "ArticleIdList": ["10.1111/j.1471-4159.2007.04613.x", "17472706"]}, {"Citation": "Thal D.R. Clearance of amyloid beta-protein and its role in the spreading of Alzheimer\u2019s disease pathology. Front. Aging Neurosci. 2015;7:25. doi: 10.3389/fnagi.2015.00025.", "ArticleIdList": ["10.3389/fnagi.2015.00025", "PMC4353250", "25805990"]}, {"Citation": "Frautschy S.A., Hu W., Kim P., Miller S.A., Chu T., Harris-White M.E., Cole G.M. Phenolic anti-inflammatory antioxidant reversal of Abeta-induced cognitive deficits and neuropathology. Neurobiol. Aging. 2001;22:993\u20131005. doi: 10.1016/S0197-4580(01)00300-1.", "ArticleIdList": ["10.1016/S0197-4580(01)00300-1", "11755008"]}, {"Citation": "Cole G.M., Morihara T., Lim G.P., Yang F., Begum A., Frautschy S.A. NSAID and antioxidant prevention of Alzheimer\u2019s disease: Lessons from in vitro and animal models. Ann. N. Y. Acad. Sci. 2004;1035:68\u201384. doi: 10.1196/annals.1332.005.", "ArticleIdList": ["10.1196/annals.1332.005", "15681801"]}, {"Citation": "Maiti P., Dunbar G.L. Use of curcumin, a natural polyphenol for targeting molecular pathways in treating age-related neurodegenerative diseases. Int. J. Mol. Sci. 2018;19:1637. doi: 10.3390/ijms19061637.", "ArticleIdList": ["10.3390/ijms19061637", "PMC6032333", "29857538"]}, {"Citation": "Wen Y., Yang S., Liu R., Simpkins J.W. Transient cerebral ischemia induces site-specific hyperphosphorylation of tau protein. Brain Res. 2004;1022:30\u201338. doi: 10.1016/j.brainres.2004.05.106.", "ArticleIdList": ["10.1016/j.brainres.2004.05.106", "15353210"]}, {"Citation": "Wen Y., Yang S., Liu R., Brun-Zinkernagel A.M., Koulen P., Simpkins J.W. Transient cerebral ischemia induces aberrant neuronal cell cycle re-entry and Alzheimer\u2019s disease-like tauopathy in female rats. J. Biol. Chem. 2004;279:22684\u201322692. doi: 10.1074/jbc.M311768200.", "ArticleIdList": ["10.1074/jbc.M311768200", "14982935"]}, {"Citation": "Pluta R., Januszewski S., Czuczwar S.J. Brain ischemia as a prelude to Alzheimer\u2019s disease. Front. Aging Neurosci. 2021;13:636653. doi: 10.3389/fnagi.2021.636653.", "ArticleIdList": ["10.3389/fnagi.2021.636653", "PMC7931451", "33679381"]}, {"Citation": "Mondragon-Rodriguez S., Perry G., Zhu X., Moreira P.I., Acevedo-Aquino M.C., Williams S. Phosphorylation of tau protein as the link between oxidative stress, mitochondrial dysfunction, and connectivity failure: Implications for Alzheimer\u2019s disease. Oxidative Med. Cell. Longev. 2013;2013:940603. doi: 10.1155/2013/940603.", "ArticleIdList": ["10.1155/2013/940603", "PMC3723250", "23936615"]}, {"Citation": "Stoothoff W.H., Johnson G.V. Tau phosphorylation: Physiological and pathological consequences. Biochim. Biophys. Acta. 2005;1739:280\u2013297. doi: 10.1016/j.bbadis.2004.06.017.", "ArticleIdList": ["10.1016/j.bbadis.2004.06.017", "15615646"]}, {"Citation": "Caughey B., Raymond L.D., Raymond G.J., Maxson L., Silveira J., Baron G.S. Inhibition of protease-resistant prion protein accumulation in vitro by curcumin. J. Virol. 2003;77:5499\u20135502. doi: 10.1128/JVI.77.9.5499-5502.2003.", "ArticleIdList": ["10.1128/JVI.77.9.5499-5502.2003", "PMC153975", "12692251"]}, {"Citation": "Rane J.S., Bhaumik P., Panda D. Curcumin inhibits tau aggregation and disintegrates preformed tau filaments in vitro. J. Alzheimer\u2019s Dis. 2017;60:999\u20131014. doi: 10.3233/JAD-170351.", "ArticleIdList": ["10.3233/JAD-170351", "28984591"]}, {"Citation": "Ma Q.L., Zuo X., Yang F., Ubeda O.J., Gant D.J., Alaverdyan M., Teng E., Hu S., Chen P.P., Maiti P., et al. Curcumin suppresses soluble tau dimers and corrects molecular chaperone, synaptic, and behavioral deficits in aged human tau transgenic mice. J. Biol. Chem. 2013;288:4056\u20134065. doi: 10.1074/jbc.M112.393751.", "ArticleIdList": ["10.1074/jbc.M112.393751", "PMC3567657", "23264626"]}, {"Citation": "Ireson C.R., Jones D.J., Orr S., Coughtrie M.W., Boocock DJWilliams M.L., Farmer P.B., Steward W.P., Gescher A.J. Metabolism of the cancer chemopreventive agent curcumin in human and rat intestine. Cancer Epidemiol. Prev. Biomark. 2002;11:105\u2013111.", "ArticleIdList": ["11815407"]}, {"Citation": "Marczylo T.H., Verschoyle R.D., Cooke D.N., Morazzoni P., Steward W.P., Gescher A.J. Comparison of systemic availability of curcumin with that of curcumin formulated with phosphatidylcholine. Cancer Chemother. Pharmacol. 2007;60:171\u2013177. doi: 10.1007/s00280-006-0355-x.", "ArticleIdList": ["10.1007/s00280-006-0355-x", "17051370"]}, {"Citation": "Sharma R.A., Steward W.P., Gescher A.J. Pharmacokinetics and pharmacodynamics of curcumin. Adv. Exp. Med. Biol. 2007;595:453\u2013470.", "ArticleIdList": ["17569224"]}, {"Citation": "Srinivasan K. Black pepper and its pungent principle-piperine: A review of diverse physiological effects. Crit. Rev. Food Sci. Nutr. 2007;47:735\u2013748. doi: 10.1080/10408390601062054.", "ArticleIdList": ["10.1080/10408390601062054", "17987447"]}, {"Citation": "Teymouri M., Barati N., Pirro M., Sahebkar A. Biological and pharmacological evaluation of dimethoxycurcumin: A metabolically stable curcumin analogue with a promising therapeutic potential. J. Cell. Physiol. 2018;233:124\u2013140. doi: 10.1002/jcp.25749.", "ArticleIdList": ["10.1002/jcp.25749", "27996095"]}, {"Citation": "Calabrese E.J. Hormesis: From mainstream to therapy. J. Cell Commun. Signal. 2014;8:289\u2013291. doi: 10.1007/s12079-014-0255-5.", "ArticleIdList": ["10.1007/s12079-014-0255-5", "PMC4390802", "25366126"]}, {"Citation": "Bielak-Zmijewska A., Grabowska W., Ciolko A., Bojko A., Mosieniak G., Bijoch \u0141., Sikora E. The role of curcumin in the modulation of ageing. Int. J. Mol. Sci. 2019;20:1239. doi: 10.3390/ijms20051239.", "ArticleIdList": ["10.3390/ijms20051239", "PMC6429134", "30871021"]}, {"Citation": "Anand P., Kunnumakkara A.B., Newman R.A., Aggarwal B.B. Bioavailability of curcumin: Problems and promises. Mol. Pharm. 2007;4:807\u2013818. doi: 10.1021/mp700113r.", "ArticleIdList": ["10.1021/mp700113r", "17999464"]}, {"Citation": "Vareed S.K., Kakarala M., Ruffin M.T., Crowell J.A., Normolle D.P., Djuric Z., Brenner D.E. Pharmacokinetics of curcumin conjugate metabolites in healthy human subjects. Cancer Epidemiol. Biomark. Prev. 2008;17:1411\u20131417. doi: 10.1158/1055-9965.EPI-07-2693.", "ArticleIdList": ["10.1158/1055-9965.EPI-07-2693", "PMC4138955", "18559556"]}, {"Citation": "Szymusiak M., Hu X., Leon Plata P.A., Ciupinski P., Wang Z.J., Liu Y. Bioavailability of curcumin and curcumin glucuronide in the central nervous system of mice after oral delivery of nano-curcumin. Int. J. Pharm. 2016;511:415\u2013423. doi: 10.1016/j.ijpharm.2016.07.027.", "ArticleIdList": ["10.1016/j.ijpharm.2016.07.027", "27426105"]}, {"Citation": "Sasaki H., Sunagawa Y., Takahashi K., Imaizumi A., Fukuda H., Hashimoto T., Wada H., Katanasaka Y., Kakeya H., Fujita M., et al. Innovative preparation of curcumin for improved oral bioavailability. Biol. Pharm. Bull. 2011;34:660\u2013665. doi: 10.1248/bpb.34.660.", "ArticleIdList": ["10.1248/bpb.34.660", "21532153"]}, {"Citation": "Kanai M., Imaizumi A., Otsuka Y., Sasaki H., Hashiguchi M., Tsujiko K., Matsumoto S., Ishiguro H., Chiba T. Dose-escalation and pharmacokinetic study of nanoparticle curcumin, a potential anticancer agent with improved bioavailability, in healthy human volunteers. Cancer Chemother. Pharmacol. 2012;69:65\u201370. doi: 10.1007/s00280-011-1673-1.", "ArticleIdList": ["10.1007/s00280-011-1673-1", "21603867"]}, {"Citation": "Peyrol J., Meyer G., Obert P., Dangles O., Pechere L., Amiot M.J., Riva C. Involvement of bilitranslocase and beta-glucuronidase in the vascular protection by hydroxytyrosol and its glucuronide metabolites in oxidative stress conditions. J. Nutr. Biochem. 2018;51:8\u201315. doi: 10.1016/j.jnutbio.2017.09.009.", "ArticleIdList": ["10.1016/j.jnutbio.2017.09.009", "29078076"]}, {"Citation": "Slevin M., Capitanescu B., Sanfeliu C., Zeinolabediny Y., AlBaradie R., Olah P., Guo B., Pirici D., Napoli M.D., Popa-Wagner A. Monomeric C-reactive protein aggravates secondary degeneration after intracerebral haemorrhagic stroke and may function as a sensor for systemic inflammation. J. Clin. Med. 2020;9:3053. doi: 10.3390/jcm9093053.", "ArticleIdList": ["10.3390/jcm9093053", "PMC7563733", "32971821"]}, {"Citation": "Mukkavilli R., Yang C., Tanwar R.S., Saxena R., Gundala S.R., Zhang Y., Ghareeb A., Floyd S.D., Vangala S., Kuo W.W., et al. Pharmacokinetic-pharmacodynamic correlations in the development of ginger extract as an anticancer agent. Sci. Rep. 2018;8:3056. doi: 10.1038/s41598-018-21125-2.", "ArticleIdList": ["10.1038/s41598-018-21125-2", "PMC5813242", "29445099"]}, {"Citation": "Tsai Y.M., Chien C.F., Lin L.C., Tsai T.H. Curcumin and its nano-formulation: The kinetics of tissue distribution and blood-brain barrier penetration. Int. J. Pharm. 2011;416:331\u2013338. doi: 10.1016/j.ijpharm.2011.06.030.", "ArticleIdList": ["10.1016/j.ijpharm.2011.06.030", "21729743"]}, {"Citation": "Yuan J., Liu W., Zhu H., Zhang X., Feng Y., Chen Y., Feng H., Lin J. Curcumin attenuates blood-brain barrier disruption after subarachnoid hemorrhage in mice. J. Surg. Res. 2017;207:85\u201391. doi: 10.1016/j.jss.2016.08.090.", "ArticleIdList": ["10.1016/j.jss.2016.08.090", "27979493"]}, {"Citation": "Tomas-Barberan F.A., Selma M.V., Espin J.C. Interactions of gut microbiota with dietary polyphenols and consequences to human health. Curr. Opin. Clin. Nutr. Metab. Care. 2016;19:471\u2013476. doi: 10.1097/MCO.0000000000000314.", "ArticleIdList": ["10.1097/MCO.0000000000000314", "27490306"]}, {"Citation": "Zam W. Gut microbiota as a prospective therapeutic target for curcumin: A review of mutual influence. J. Nutr. Metab. 2018;2018:1367984. doi: 10.1155/2018/1367984.", "ArticleIdList": ["10.1155/2018/1367984", "PMC6311836", "30647970"]}, {"Citation": "McIntosh F.M., Maison N., Holtrop G., Young P., Stevens V.J., Ince J., Johnstone A.M., Lobley G.E., Flint H.J., Louis P. Phylogenetic distribution of genes encoding \u03b2-glucuronidase activity in human colonic bacteria and the impact of diet on faecal glycosidase activities. Environ. Microbiol. 2012;14:1876\u20131887. doi: 10.1111/j.1462-2920.2012.02711.x.", "ArticleIdList": ["10.1111/j.1462-2920.2012.02711.x", "22364273"]}, {"Citation": "O\u2019Toole P.W., Jeffery I.B. Gut microbiota and aging. Science. 2015;350:1214\u20131215. doi: 10.1126/science.aac8469.", "ArticleIdList": ["10.1126/science.aac8469", "26785481"]}, {"Citation": "Battaglini D., Pimentel-Coelho P.M., Robba C., Dos Santos C.C., Cruz F.F., Pelosi P., Rocco P.R.M. Gut microbiota in acute ischemic stroke: From pathophysiology to therapeutic implications. Front. Neurol. 2020;11:598. doi: 10.3389/fneur.2020.00598.", "ArticleIdList": ["10.3389/fneur.2020.00598", "PMC7330114", "32670191"]}, {"Citation": "Bonsack B., Jiang R.H., Borlongan C.V. A gut feeling about stroke reveals gut-brain axis\u2019 active role in homeostasis and dysbiosis. J. Cereb. Blood Flow Metab. 2020;40:1132\u20131134. doi: 10.1177/0271678X19900037.", "ArticleIdList": ["10.1177/0271678X19900037", "PMC7181096", "32063084"]}, {"Citation": "Holmes A., Finger C., Morales-Scheihing D., Lee J., McCullough L.D. Gut dysbiosis and age-related neurological diseases; an innovative approach for therapeutic interventions. Transl. Res. 2020;226:39\u201356. doi: 10.1016/j.trsl.2020.07.012.", "ArticleIdList": ["10.1016/j.trsl.2020.07.012", "PMC7590960", "32755639"]}, {"Citation": "Liu J., Zhang T., Wang Y., Si C., Wang X., Wang R.T., Lv Z. Baicalin ameliorates neuropathology in repeated cerebral ischemia-reperfusion injury model mice by remodeling the gut microbiota. Aging (Albany NY) 2020;12:3791\u20133806. doi: 10.18632/aging.102846.", "ArticleIdList": ["10.18632/aging.102846", "PMC7066900", "32084011"]}, {"Citation": "Ohno M., Nishida A., Sugitani Y., Nishino K., Inatomi O., Sugimoto M., Kawahara M., Andoh A. Nanoparticle curcumin ameliorates experimental colitis via modulation of gut microbiota and induction of regulatory T cells. PLoS ONE. 2017;12:e0185999. doi: 10.1371/journal.pone.0185999.", "ArticleIdList": ["10.1371/journal.pone.0185999", "PMC5630155", "28985227"]}, {"Citation": "Shen L., Liu L., Ji H.-F. Regulative effects of curcumin spice administration on gut microbiota and its pharmacological implications. Food Nutr. Res. 2017;61:1361780. doi: 10.1080/16546628.2017.1361780.", "ArticleIdList": ["10.1080/16546628.2017.1361780", "PMC5553098", "28814952"]}, {"Citation": "Chen Y.M., Chiu W.C., Chiu Y.S., Li T., Sung H.C., Hsiao C.Y. Supplementation of nano-bubble curcumin extract improves gut microbiota composition and exercise performance in mice. Food Funct. 2020;11:3574\u20133584. doi: 10.1039/C9FO02487E.", "ArticleIdList": ["10.1039/C9FO02487E", "32271330"]}, {"Citation": "Scazzocchio B., Minghetti L., D\u2019Archivio M. Interaction between gut microbiota and curcumin: A new key of understanding for the health effects of curcumin. Nutrients. 2020;12:E2499. doi: 10.3390/nu12092499.", "ArticleIdList": ["10.3390/nu12092499", "PMC7551052", "32824993"]}, {"Citation": "F\u00eelfan M., Sandu R.E., Z\u0103v\u0103leanu A.D., Gre\u015fit\u0103 A., Gl\u0103van D.G., Olaru D.G., Popa-Wagner A. Autophagy in aging and disease. Rom. J. Morphol. Embryol. 2017;58:27\u201331.", "ArticleIdList": ["28523294"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "12", "Day": "18"}, {"Year": "2022", "Month": "1", "Day": "1"}, {"Year": "2022", "Month": "1", "Day": "3"}, {"Year": "2022", "Month": "1", "Day": "21", "Hour": "1", "Minute": "17"}, {"Year": "2022", "Month": "1", "Day": "22", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "2", "Day": "2", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "1", "Day": "7"}], "PublicationStatus": "epublish", "ArticleIdList": ["35057429", "PMC8779038", "10.3390/nu14020248", "nu14020248"]}}], "PubmedBookArticle": []}